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AgrD is the precursor for the autoinducing peptide
in a quorum-sensing system regulating virulence
phenotypes of the preeminent pathogen Staphylo-
coccus aureus. Mass spectrometry-based methods,
including molecular networking, identified formy-
lated and nonformylated peptide variants derived
from the AgrD N-terminal leader domain in
S. aureus cell-free culture supernatants. Functional
assessment of these peptides revealed unexpected
bioactivities, including human cell-line cytotoxicity,
modulation of neutrophil chemotaxis, neutrophil
extracellular trap formation, and the aggravation of
skin lesions in vivo.
INTRODUCTION
Nearly three decades ago, the accessory gene regulatory (Agr)
quorum-sensing system was identified in the leading human
bacterial pathogen Staphylococcus aureus (Recsei et al.,
1986). A classical model of growth phase-dependent gene regu-
lation, Agr is studied for its important role in regulation of surface-
expressed or secreted virulence factors. Natural or engineered
strains of S. aureus with inactivating mutations in agr genes
lose virulence in animal infection (Abdelnour et al., 1993; Villaruz
et al., 2009). Thus, S. aureus infectivity depends upon an array of
Agr-regulated gene products working in concert to circumvent
host innate immune clearance (Novick et al., 1993; Pragman
and Schlievert, 2004), yet many mechanistic details of the Agr
system remain a mystery.
Agr quorum-sensing dynamics are governed by the posttrans-
lationally modified, thiolactone-containing autoinducing peptide
(AIP) (Enright et al., 2002). Genetically, agr is composed of two
promoters, P2 and P3, which direct the divergent transcription
of RNAII and RNAIII according to AIP concentrations. RNAII en-
codes the four-gene operon agrABCD, and within the cluster,
AgrB+AgrD and AgrA+AgrC work together to carry out biosyn-
thesis and regulatory functions. AgrD, the AIP precursor sub-
strate, is cleaved and cyclized through thiolactone formationChemistry & Biology 21, 1457–146by cell membrane-bound AgrB. AgrA and AgrC combine to
form a kinase-dependent two-component regulatory system.
During critical regulatory states, the mature AIP binds extracellu-
larly to the AgrC protein kinase, triggering activation of agrA
and successive induction of divergently expressed promoters
P2 and P3. RNAIII expression leads to production of two mole-
cules, the primary effector RNA regulator and delta-toxin or
phenol-soluble modulin (PSM) g, a wide-spectrum cytolysin
that is released extracellularly with a formylated initiator methio-
nine, with a nonformylated methionine, or in truncated forms
(Gonzalez et al., 2012). Taxonomically, S. aureus isolates can
be divided into four agr groups on the basis of polymorphisms
within the agrABCD operon (Wright et al., 2005).
Downstream contributions of the mature AIP on S. aureus
pathogenesis have been the focus of several studies (Harraghy
et al., 2007). More recently, reports described the biochemistry
of each individual gene product and the relationship between
the enzyme AgrB and its substrate AgrD (Thoendel and Horswill,
2009). It is thought that formation of the AIP is initiated by migra-
tion of AgrD and its association with the intracellular membrane.
The amphipathic AIP N-terminal region contains essential amino
acids that stabilize the propeptide, allowing association of core
and C-terminal amino acids with AgrB. Endopeptidase AgrB
then cleaves the highly conserved C-terminal tail of AgrD to cata-
lyze the formation of a thiolactone ring within the core amino
acids. Thereafter, through an unknown mechanism, the AIP pre-
cursor is transported across the cell membrane. Once extracel-
lular, the type I signal peptidase SpsB (Kavanaugh et al., 2007)
catalyzes the formation of two extracellular final products: (1)
AIP and (2) N-terminal peptide (Figure 1A).
Using molecular networking (Watrous et al., 2012), we exam-
ined mass spectrometry (MS) data derived from cell-free culture
extracts of a representative community-associated methicillin-
resistant S. aureus (MRSA) USA300 isolate (Kennedy et al.,
2010). Analysis of the molecular network revealed extracellular
AgrD N-terminal (termed N-AgrD) formylated and truncated pep-
tide variants. Here we show these N-AgrD variant peptides have
immunostimulatory properties toward neutrophils isolated from
human blood, display broad-spectrum cytotoxicity, and aggra-
vate skin lesion formation caused by Agr-deficient S. aureus.
This study provides insight into endogenous biosynthetic and
virulence properties of the Agr quorum-sensing system, while2, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1457
Figure 1. The Accessory Gene Regulatory System and N-AgrD Peptide Properties
(A) Four genes, agrABCD, comprise the agr biosynthetic network. agrD encodes the peptide substrate undergoes posttranslational modification (PTM) by
membrane-bound endopeptidase agrB through cleavage and thiolactone cyclization. Once extracellular, the hybrid molecule consisting of the AIP and the
N-terminal region of AgrD is further processed by peptidase SpsB into mature AIP and N-AgrD. Induction of promoter 2 drives the transcription of the agrABCD
operon. Promoter 3 induction results in the expression of RNAIII that produces two final products, the primary RNA effector molecule and PSMg.
(B) MS survey of several S. aureus clinical isolates show detectable N-AgrD peptides as peptide counts.
(C) TandemMS sequencing of AgrD F24. Several contingent ion fragments, including reliable mass accuracy, localize a PTM of +28 Da to the initiator methionine
of N-AgrD.
(D) Antibiotic effects on the number of N-AgrD peptide counts. Challenge with a subinhibitory concentration of daptomycin increased the number of detectable
peptides.
Statistical analysis performed by one-way ANOVA; ***p < 0.001. Data are expressed as mean ± SD.
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domain. Furthermore, we highlight the power of the molecular
networking platform as a tool to discover unforeseen bioactive
peptides within a long-studied, highly important regulatory sys-
tem of staphylococcal virulence.
RESULTS
Discovery of N-AgrD Variant Peptides by MS-Based
Molecular Networking
Molecular networking is an emerging platform based on the
concept of mass spectral pairing, which allows the structural
grouping and successive mapping of MS data sets. Recently,
our group used the platform to build a molecular network
representative of extracellularly released, small molecular weight1458 Chemistry & Biology 21, 1457–1462, November 20, 2014 ª2014biosynthetic factors produced by MRSA (Gonzalez et al., 2014).
Here, we report the continued examination of the createdmolec-
ular network by de novo sequencing and peptidogenomic ap-
proaches (Kersten et al., 2011), recovering peptides pertaining
to the AgrD N-terminal domain (Figure S1 available online).
Investigation into the identity of each individual mass spectrum
within the AgrD grouped family-produced peptide sequence
tags corresponding to N-terminal variants with mass offsets
of +28 Da, a signature for formyl-methionine modification. With
the recovered chemical knowledge from the molecular net-
works, we used tandem MS data processing program InsPecT
(Tanner et al., 2005) to support the de novo sequencing and pep-
tidogenomics identifications. Careful manual annotation of the
identified N-AgrD peptides further validated the identifications










Figure 2. N-AgrD Peptide Variants Stimu-
late Polymorphonuclear Neutrophil Chemo-
taxis and NET Formation
(A) As an indicator of migration, elastase enzy-
matic activity in neutrophil supernatants was
measured at 405 nm. Formylated peptides N-
AgrD F20 and N-AgrD F24 stimulated increased
chemotaxis. The N-AgrD D20 peptide, which is
nonformylated, did not exhibit chemoattractant
properties.
(B) PMN calcium influx indicating receptor acti-
vation. A significant decrease in activation was
observed by each pharmacological blockade,
indicating that the N-AgrD peptide family
functions though a formyl peptide receptor-
dependent mechanism. BI, BOC, a selective in-
hibitor of FPR1; PI, PBP, a selective inhibitor
of FPR2.
(C) The Quant-iT Picogreen assay was used
to quantify extracellular DNA release upon
stimulation by the N-AgrD peptides. Only formylated peptide N-AgrD F20 stimulated a significant increase in NET production.
(D) Microscopy confirmed only peptide N-AgrD D20 stimulated formation of web-like DNA structures similar to the phorbol myristate acetate positive control.
Statistical analysis by one-way ANOVA; ***p < 0.001. Data are expressed as mean ± SD.
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ical isolates (Table S1). N-AgrD peptides were produced by three
USA300 lineage MRSA, two ST59 MRSA (Huang et al., 2012),
and clonal colony ST45 of USA600 MRSA lineage (Figure 1C).
In successive MS experiments, peptide sequences most abun-
dantly mapped to AgrD (McIlwain et al., 2012), herein designated
(1) N-AgrD F20, (2) N-AgrD F24, and (3) N-AgrD D20, were syn-
thesized and isolated at >95% purity for functional assessment.
Properties of the N-AgrD Variant Peptides
To estimate the production and release of the N-AgrD variants,
MRSA USA300 cell-free cultures were extracted and examined
by tandem MS. N-AgrD peptides were detected only in late
exponential phase extracts, in agreement with previous reports
on the temporal production of the AIP (Junio et al., 2013). Esti-
mated AIP culture concentrations vary from 2 to 10 mM (Junio
et al., 2013); therefore, we predicted that N-AgrD peptide vari-
ants would be detected in stoichiometric concentrations. We de-
tected 2 to 3 mM N-AgrD F24 in extracted cultures of USA300
strain TCH1516 and 1 to 2 mM in extracted cultures of the
ST59 strain. There was increased abundance of N-AgrD pep-
tides upon exposure of MRSA to subinhibitory concentrations
of cell-wall active antibiotics daptomycin (0.125 mg/l) or vanco-
mycin (0.125 mg/l), or human cationic defense peptide LL-37
(1.2 mg/l) (Figure 1D).
Polymorphonuclear Neutrophil Chemotaxis Induced by
N-AgrD Formylated Variants
Leukocytes of the host innate immune system recognize formy-
lated bacterial products as pathogen-associated molecular
patterns (Mogensen, 2009), as mediated through formyl peptide
receptors (FPR), a class of G protein-coupled receptors associ-
ated with chemotaxis. The human FPR family is composed of
three members, FPR1, FPR2/ALX, and FPR3; only the first
two are expressed in neutrophils. Recently, members of the
S. aureus-derived phenol-soluble modulin (PSM) peptide family
were shown to selectively activate FPR2/ALX (KretschmerChemistry & Biology 21, 1457–146et al., 2010). BecauseN-AgrD F20 andN-AgrDF24peptides con-
tained formyl groups, we tested their abilities to act as chemoat-
tractants for human neutrophils. Nanomolar quantities of N-AgrD
F20, N-AgrD F24, and N-AgrD D20 were placed in a chamber
adjacent to a suspension of freshly isolated neutrophils, and
chemotaxis was quantified. Both formylated peptides N-AgrD
F20 and F24 showed strong chemoattractant properties compa-
rable with the well-known chemoattractant formyl-methionyl-
leucyl-phenylalanine, whereas nonformylated N-AgrD D20 did
not stimulate chemotaxis (Figure 2A). Using specific antagonists
of theFPR1andFPR2 receptors andcalcium influx asa surrogate
measure of receptor activation (Dixit et al., 2012), significant de-
creases in receptor activation were observed by pharmacolog-
ical blockade, indicating that the N-AgrD peptides function
though a FPR-dependent mechanism (Figure 2B).
NET Induction by the N-AgrD F20 Formylated Peptide
Neutrophil extracellular trap (NET) formation is a specialized cell
death process wherein nuclear DNA is extruded to ensnare and
kill pathogens (Brinkmann et al., 2004). As quantified by DNA
release, AgrD F20 strongly stimulated NET formation (Figure 2C),
whereas no stimulatory effects were observed with peptides N-
AgrD F24 and N-AgrD D20. N-AgrD F20 stimulation of NETs was
corroborated by fluorescence microscopy, which showed the
hallmark weblike NET structures were formed by neutrophils
upon N-AgrD F20 stimulation (Figure 2D).
N-AgrD Variant Peptides Cytotoxicity against Human
Cell Lines and Erythrocytes
Hemolytic ability of the N-AgrD peptides was tested against
erythrocytes from freshly washed human blood. N-AgrD F20
and N-AgrD F24 showed significant hemolytic activity, but N-
AgrD D20 peptide did not induce erythrocyte lysis (Figure 3A).
USA300 MRSA are associated with complicated skin and soft
tissue infections and severe necrotizing pneumonia, as the path-
ogen breaks down host epithelial tissue barriers (Lim et al., 2012;
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Figure 3. Erythrocyte Hemolysis, Cytotoxic Properties of N-AgrD against Epithelial Cells, and Murine Models of Infection
(A) Heparinized humanwhole bloodwas processed and treatedwith N-ArgD peptides or saline control. N-AgrD F20 andN-AgrD F24 showedmoderate hemolysis
activity. The N-AgrD D20 peptide did not cause hemolysis.
(B and C) A549 human alveolar epithelial cell (B) and HaCaT human keratinocyte cell lines (C) were incubated with N-AgrD peptides for 120 min; cell damage was
monitored by LDH release. All three peptides displayed significant cytolytic activity. Statistical analysis by one-way ANOVA; ***p < 0.001.
(D) Fluorescent microscopy of A549 cells after live/dead cell staining.
(E) In vivo contribution of the N-AgrD F20 and N-AgrD F24 peptides as assessed in murine lesion infection models. Subcutaneous infection of C57Bl/6 mice with
an S. aureus agr null strain was tested with and without the addition of a 1:1 mixture of AgrD F20 and AgrD F24 (10 mg/ml) on contralateral flanks. Statistical
analysis was performed by Student’s t test; **p < 0.01.
(F) Appearance of a representative infectedmouse flank shows that addition of the N-AgrD F20 + N-AgrD F24 peptides to the S. aureus agr null strain results in an
approximate doubling of lesion area.
All statistical data are expressed as mean ± SD.
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lial cell line (A549) and a human keratinocyte cell line (HaCaT). As
measured by lactate dehydrogenase (LDH) release, N-AgrD F20
and N-AgrD F24 formylated peptides exhibited twice the cyto-
lytic activity against both tissue cell lines as the nonformylated
N-AgrD peptide (Figures 3B and 3C). A549 and HaCaT cytotox-
icity was corroborated by live/dead cell counts (Figures S7A and
S7B) and visual assessment by microscopy (Figure 3D; Fig-
ure S7C). Additionally, a scrambled-sequence peptide was
included as a negative control and showed no activity, verifying
that N-AgrD bioactivity is sequence-specific.
N-AgrD Peptides Aggravate Skin Lesions in a Murine
Model
S. aureus is the most common cause of skin and soft tissue in-
fections in humans, and the majority of the isolates cultured
from these infections are predominately agr positive. We sought
to determine the contribution of N-AgrD peptides to disease pro-1460 Chemistry & Biology 21, 1457–1462, November 20, 2014 ª2014gression in vivo independent of the well-established role of the
Agr system in virulence. To that end, we inoculated mice subcu-
taneously with the agr null strain S. aureus RN6911 in the pres-
ence or absence of a micromolar mixture of the N-AgrD F20
and N-AgrD F24. Presence of the N-AgrD peptides significantly
increased ensuing lesion sizes (Figure 3E). After 72 hr, the lesion
sizes caused by the RN6911 strain harvesting the N-AgrD pep-
tides were approximately double in size (Figures 3E and 3F)
despite equal bacterial loads (Figure S8), consistent with the
endogenous proinflammatory and cytotoxic properties of these
peptides observed in our in vitro testing. Permission to under-
take experiments was obtained from the Animal Subject Ethics
Committee of the University of California, San Diego.
DISCUSSION
The current functional assignment for the N-terminal region of
AgrD indicates the amphipathic peptide governs intercellularElsevier Ltd All rights reserved
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(Zhang et al., 2004). Our study shows the extracellular release
of N-AgrD as a set of bioactive structurally diverse peptides,
including formylated variants. These findings indicate that
S. aureus has evolved to maximize or chemically salvage its pro-
tein repertoire in order to gain ecological fitness.
N-AgrD structurally resembles the PSM toxin family in
S. aureus. PSMs are cytolytic, formylated and nonformylated
peptide variants that are upregulated in community-associ-
ated MRSA and genetically linked to the agr system (PSMg
is embedded within RNAIII) (Wang et al., 2007; Gonzalez
et al., 2014). Because of the structural similarities between
peptides, N-AgrD could play a potential role in biofilm struc-
tural formation as demonstrated for PSMs (Periasamy et al.,
2012). In concurrence with the work herein, N-AgrD was
recently shown to be a constituent of amyloid fibrils of biofilms
and possess further cellular functions akin to PSMs (Schwartz
et al., 2014).
Mechanisms governing the amounts of N-AgrD participating
in amyloid fibrils (biofilm) versus free to the surrounding envi-
ronment is likely a dynamic process governed by environmental
stimuli. This notion is supported by our observation that sub-
inhibitory concentrations of cell-wall inhibiting antibiotics or
LL-37 increased abundance of N-AgrD peptides in a similar
manner to PSMs (Gonzalez et al., 2012). The interplay between
promiscuous S. aureus exoproteases and the AgrD leader
domain may lead to the wide repertoire of N-AgrD variants.
Proteolysis studies on the AIP showed S. aureus supernatants
produced variant cleavage products of the N-terminal AgrD
domain independent of SpsB (Kavanaugh et al., 2007). Our
accumulated studies on the AgrD leader domain show unfore-
seen, yet important components of the now classical agr
pathway.
In summary, we applied MS-based tools to identify N-AgrD
variants that possess cytotoxic and proinflammatory activ-
ities. These peptides potentially modulate S. aureus disease
manifestations, and suggest that the N-terminal leader domain
of this protein is not simply an innocuous castoff during process-
ing of the mature AIP. Like many pattern recognition molecules
with mixed proinflammatory and toxic activities, their effect on
the host is complex and likely to vary dependent on the
site, stage, and magnitude of infection. Therefore, the effects
N-AgrD variants have on S. aureus gene regulation (i.e., AgrA-
AgrC signaling) merits further study. Ultimately, this work exem-
plifies the use of an emerging tool like molecular networking can
aid in elucidating molecules that influence the establishment of
infection, leading to better understanding their broader impact
on the pathogen-host interaction.
SIGNIFICANCE
Our results reveal that the N-terminal leader end of the AIP
substrate AgrD is an extracellularly released peptide exist-
ing in variant forms with unexpected bioactivities in vitro
and in vivo. These peptides may play a role in MRSA viru-
lence; before this study, only the core amino acids of mature
AgrD were believed to contribute to bacterium’s pathogenic
cycle. This project arose by the application of the new and
emerging tool of MS-based molecular networking, whichChemistry & Biology 21, 1457–146highlights the value of integrating cutting-edge analytical
tools to the study of biological systems. Because the com-
plex array of virulence factors produced byMRSA is not fully
understood, it is critical to apply new strategies that extend
beyond the classical paradigm of proteomic identification.
These new technologies can lead to unforeseen information
on the molecular repertoire of human pathogens.
EXPERIMENTAL PROCEDURES
Identification of N-AgrD by MS
S. aureus cultures (Table S1) were grown in Todd-Hewitt broth at 37C to late
exponential-early stationary growth phase and pelleted at 4,000 rpm 3
10 min, and 1 ml supernatant was collected, extracted with an equal volume
of 1-butanol, and dried by SpeedVac. SDS-PAGE gels showed no Coomassie
staining indicative of larger proteins; therefore, the extracts were considered
to contain peptides and other small molecular weight species. Solid extracts
were resuspended and processed by Thermo-Finnegan linear trap quadruple
liquid chromatography tandem MS. Peptidogenomic annotation of the
collected tandem MS data indicated sequence tags of the N-AgrD, and
mass offsets of +28 Da were localized to the N-terminal methionine residue.
Targeted use of the MS processing program InsPecT identified several N-
AgrD variant peptides with formylated initiator methionine residues. Here
we focused on the three most abundant and highest scoring peptides ob-
tained from InsPecT, after validation of the assignments by manual
annotation.
Synthetic Peptides
The following peptides were synthesized by American Peptide: (1)
N-AgrD F20: formyl-MNTLFNLFFDFITGILKNIG; (2) N-AgrD F24: formyl-
MNTLFNLFFDFITGILKNIGNIAA; (3) N-AgrD D20: FNLFFDFITGILKNIGNIAA;
and (4) scramble peptide N-AgrD D20: NIAKFFLTIILFNNDFGAGI. Additional
experimental procedures can be found in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2014.09.015.
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